NCT02171065View on ClinicalTrials.gov

PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.

NACompletedINTERVENTIONAL
Enrollment

902

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Acute Coronary Syndrome (ACS)
Interventions
DEVICE

sham

DEVICE

ABSORB BVS

Trial Locations (1)

221 85

David Erlinge, Lund

Sponsors
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Infraredx

INDUSTRY

collaborator

The Medicines Company

INDUSTRY

lead

Uppsala University

OTHER